• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重大流行 2009 年 H1N1 流感疾病是由致病免疫复合物引起的。

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.

机构信息

Fundacion INFANT, Buenos Aires, Argentina.

出版信息

Nat Med. 2011 Feb;17(2):195-9. doi: 10.1038/nm.2262. Epub 2010 Dec 5.

DOI:10.1038/nm.2262
PMID:21131958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3034774/
Abstract

Pandemic influenza viruses often cause severe disease in middle-aged adults without preexisting comorbidities. The mechanism of illness associated with severe disease in this age group is not well understood. Here we find preexisting serum antibodies that cross-react with, but do not protect against, 2009 H1N1 influenza virus in middle-aged adults. Nonprotective antibody is associated with immune complex-mediated disease after infection. We detected high titers of serum antibody of low avidity for H1-2009 antigen, and low-avidity pulmonary immune complexes against the same protein, in severely ill individuals. Moreover, C4d deposition--a marker of complement activation mediated by immune complexes--was present in lung sections of fatal cases. Archived lung sections from middle-aged adults with confirmed fatal influenza 1957 H2N2 infection revealed a similar mechanism of illness. These observations provide a previously unknown biological mechanism for the unusual age distribution of severe cases during influenza pandemics.

摘要

大流行性流感病毒常导致无潜在合并症的中年成年人发生严重疾病。对于该年龄组中与严重疾病相关的发病机制尚不清楚。在这里,我们发现中年成年人中预先存在的血清抗体与 2009 年 H1N1 流感病毒发生交叉反应,但不能预防该病毒。非保护性抗体与感染后免疫复合物介导的疾病有关。我们在重症患者中检测到针对 H1-2009 抗原的低亲和力血清抗体和针对同一蛋白的低亲和力肺免疫复合物的高滴度。此外,在致命病例的肺组织切片中存在 C4d 沉积——一种由免疫复合物介导的补体激活的标志物。从中年成年人确诊的致死性流感 1957 年 H2N2 感染的存档肺组织切片中揭示了一种类似的发病机制。这些观察结果为流感大流行期间严重病例的异常年龄分布提供了一个以前未知的生物学机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/dcbc47b252da/nihms247007f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/57e2694980ac/nihms247007f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/f6250b26a579/nihms247007f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/5521a616c173/nihms247007f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/dcbc47b252da/nihms247007f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/57e2694980ac/nihms247007f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/f6250b26a579/nihms247007f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/5521a616c173/nihms247007f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/3034774/dcbc47b252da/nihms247007f4.jpg

相似文献

1
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.严重大流行 2009 年 H1N1 流感疾病是由致病免疫复合物引起的。
Nat Med. 2011 Feb;17(2):195-9. doi: 10.1038/nm.2262. Epub 2010 Dec 5.
2
Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.健康志愿者体内针对大流行的A/加利福尼亚/07/2009(H1N1)流感病毒的血清型特异性或交叉反应性神经氨酸酶抑制抗体。
BMC Res Notes. 2015 Apr 10;8:136. doi: 10.1186/s13104-015-1086-z.
3
High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.针对流感疫苗抗原的非中和抗体的高滴度和高亲和力与严重流感相关。
Clin Vaccine Immunol. 2012 Jul;19(7):1012-8. doi: 10.1128/CVI.00081-12. Epub 2012 May 9.
4
Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis.2009 年大流行流感 A(H1N1)致死病例肺组织中的细胞因子和趋化因子谱:宿主免疫反应在发病机制中的作用。
Am J Pathol. 2013 Oct;183(4):1258-1268. doi: 10.1016/j.ajpath.2013.06.023. Epub 2013 Aug 11.
5
Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.2009年甲型H1N1流感大流行感染后儿童和成人对流感病毒的交叉反应性免疫。
Antiviral Res. 2015 Feb;114:106-12. doi: 10.1016/j.antiviral.2014.12.008. Epub 2014 Dec 13.
6
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.评估新型甲型 H1N1 流感病毒在不同年龄段的基线抗体流行率和感染发病率。
Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.
7
Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.与年龄相关的 2009 年甲型 H1N1 流感病毒亚型的交叉反应性抗体依赖的细胞毒性。
J Infect Dis. 2013 Oct 1;208(7):1051-61. doi: 10.1093/infdis/jit294. Epub 2013 Jun 28.
8
Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.针对健康人群和流感感染人群的大流行性 A/H1N1 流感病毒的神经氨酸酶抗体。
PLoS One. 2018 May 9;13(5):e0196771. doi: 10.1371/journal.pone.0196771. eCollection 2018.
9
Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.上海人群中对 2009 年大流行 H1N1 流感病毒具有高中和活性的预先存在的免疫。
PLoS One. 2013;8(3):e58810. doi: 10.1371/journal.pone.0058810. Epub 2013 Mar 19.
10
Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.测定流感样病例和高危人群对 2009 年人感染流感 H1N1 病毒的抗体反应。
Asian Pac J Allergy Immunol. 2010 Mar;28(1):67-75.

引用本文的文献

1
Anti-pA137R antibodies exacerbate the pathogenicity of African swine fever virus in pigs.抗pA137R抗体加剧非洲猪瘟病毒在猪身上的致病性。
J Virol. 2025 Jun 17;99(6):e0017225. doi: 10.1128/jvi.00172-25. Epub 2025 May 29.
2
The intersection of influenza infection and autoimmunity.流感感染与自身免疫的交叉点。
Front Immunol. 2025 Apr 3;16:1558386. doi: 10.3389/fimmu.2025.1558386. eCollection 2025.
3
How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza.广泛中和抗体如何重新定义对流感的免疫力

本文引用的文献

1
Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?糖基化作为原始抗原性失误的修饰物是否可以解释大流行性新型 H1N1 流感的病例年龄分布和异常毒性?
BMC Infect Dis. 2010 Jan 7;10:5. doi: 10.1186/1471-2334-10-5.
2
Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.肺炎链球菌合并感染与 H1N1 大流行流感的严重程度相关。
PLoS One. 2009 Dec 31;4(12):e8540. doi: 10.1371/journal.pone.0008540.
3
Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population.
Antibodies (Basel). 2025 Jan 7;14(1):4. doi: 10.3390/antib14010004.
4
Antibody Avidity Maturation Following Booster Vaccination with an Intranasal Adenovirus Salnavac Vaccine.鼻内腺病毒疫苗Salnavac加强免疫后抗体亲和力成熟
Vaccines (Basel). 2024 Dec 2;12(12):1362. doi: 10.3390/vaccines12121362.
5
The role of antibody-dependent enhancement in dengue vaccination.抗体依赖增强作用在登革热疫苗接种中的角色。
Trop Dis Travel Med Vaccines. 2024 Nov 1;10(1):22. doi: 10.1186/s40794-024-00231-2.
6
Effect of Mixed Probiotics on Alleviating H1N1 Influenza Infection and Regulating Gut Microbiota.混合益生菌对减轻甲型H1N1流感感染及调节肠道微生物群的作用
Foods. 2024 Sep 27;13(19):3079. doi: 10.3390/foods13193079.
7
Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist α-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs.不变自然杀伤T细胞激动剂α-半乳糖神经酰胺的辅助使用导致流感疫苗接种猪出现与疫苗相关的呼吸道疾病加重。
Vaccines (Basel). 2024 Sep 18;12(9):1068. doi: 10.3390/vaccines12091068.
8
Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine.既往免疫和年龄对减毒活流感疫苗抗体反应的影响。
Vaccines (Basel). 2024 Aug 1;12(8):864. doi: 10.3390/vaccines12080864.
9
The Phenomenon of Thrombotic Microangiopathy in Cancer Patients.癌症患者的血栓性微血管病现象。
Int J Mol Sci. 2024 Aug 21;25(16):9055. doi: 10.3390/ijms25169055.
10
Mechanisms of antibody-dependent enhancement of infectious disease.抗体依赖性传染病增强机制。
Nat Rev Immunol. 2025 Jan;25(1):6-21. doi: 10.1038/s41577-024-01067-9. Epub 2024 Aug 9.
一般人群中针对猪源 H1N1 流感病毒的预先存在的免疫性。
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70. doi: 10.1073/pnas.0911580106. Epub 2009 Nov 16.
4
Lung pathology in fatal novel human influenza A (H1N1) infection.新型致命性人感染甲型 H1N1 流感的肺部病理学改变。
Am J Respir Crit Care Med. 2010 Jan 1;181(1):72-9. doi: 10.1164/rccm.200909-1420OC. Epub 2009 Oct 29.
5
Critical care services and 2009 H1N1 influenza in Australia and New Zealand.澳大利亚和新西兰的重症监护服务与2009年甲型H1N1流感
N Engl J Med. 2009 Nov 12;361(20):1925-34. doi: 10.1056/NEJMoa0908481. Epub 2009 Oct 8.
6
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.对2009年甲型H1N1流感大流行病毒的交叉反应性抗体应答。
N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.
7
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses.新型猪源H1N1流感病毒的体外和体内特性研究
Nature. 2009 Aug 20;460(7258):1021-5. doi: 10.1038/nature08260.
8
Severe respiratory disease concurrent with the circulation of H1N1 influenza.与甲型H1N1流感病毒传播同时出现的严重呼吸道疾病。
N Engl J Med. 2009 Aug 13;361(7):674-9. doi: 10.1056/NEJMoa0904023. Epub 2009 Jun 29.
9
Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico.墨西哥出现的源自猪的甲型H1N1流感所致肺炎及呼吸衰竭
N Engl J Med. 2009 Aug 13;361(7):680-9. doi: 10.1056/NEJMoa0904252. Epub 2009 Jun 29.
10
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.接种季节性流感疫苗后对新型甲型H1N1流感病毒的血清交叉反应抗体应答。
MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4.